Health IT vendors Cerner and Lumeris have announced a long-term partnership and a new product offering, Maestro Advantage, for value-based arrangements, including Medicare Advantage and provider-sponsored health plans.
As part of the relationship, Cerner is investing an undisclosed amount in Lumeris’ parent company, Essence Group Holdings Corp., to accelerate outreach to health systems transitioning to value-based care.
Lumeris develops technology solutions and strategic advising services to healthcare organizations around value-based care. It operates a cloud-based Accountable Delivery System Platform (ADS), which provides accountable care and integration of claims, EHR, lab and pharmacy data.
The companies said the new offering combines Cerner and Lumeris technology and services to streamline redundant processes that burden the patient and provider, including lengthy claims processing and reimbursement cycles, and obstacles to sharing data and records.
Maestro Advantage is designed to help providers more effectively assess risk and create interventions and better maximize outcomes for patients enrolled in value-based arrangements, such as PSHPs and MA plans. Its goal is to manage health systems’ increasingly complex mix of owned- and affiliated-provider relationships across any EHR in the network.
As part of the relationship, Lumeris will adopt Cerner’s HealtheIntent population health platform and combine its clinical methodology and advanced analytics. Initial deployments are expected to begin in the second half of 2018. An executive steering committee of members from Lumeris and Cerner leadership will provide oversight and governance of the strategy, business development, client delivery and continuous innovation of Maestro Advantage.
